Breaking
NOW LEADING Garrett Fienberg named CEO of Truveris MISSION Making PBM pricing transparent for employers 2026 Truveris launches pharmacy Center of Excellence TRACK RECORD Four startups founded, operated, and sold CREDENTIALS Kellogg MBA - Michigan, summa cum laude
Profile - Healthcare Technology

Garrett Fienberg

The CEO turning pharmacy claims data into leverage - so employers can finally see what their drug benefits actually cost.

Chief Executive Officer Truveris Pharmacy Cost Containment
Garrett Fienberg, CEO of Truveris
Garrett Fienberg / CEO, Truveris
The Story

Betting that visibility beats the middleman


Garrett Fienberg runs Truveris on a single, stubborn idea: employers deserve to see exactly what their pharmacy benefits cost, and competition - not opacity - is what brings those costs down.

Truveris describes itself as a pharmacy cost containment company. In plain terms, it has built an independent, data-led technology platform that opens up the pricing inside pharmacy benefit managers, the intermediaries that sit between employers and the drugs their employees take. Where most of that market runs on information the buyer never sees, Truveris turns pharmacy claims and PBM contracts into something an employer can actually read, question, and negotiate against.

Fienberg is the person now steering that mission. He joined the company in 2021 as head of growth operations, was elevated to Chief Operating Officer in March 2024, and stepped into the CEO seat in 2025. It is a fast climb, but a logical one for someone whose entire career has been about building the engine that makes a business grow.

In His Words
Pharmacy costs are one of the most complex drivers of benefit spend. Garrett Fienberg, CEO of Truveris

That complexity is the whole reason Truveris exists. Employers spend enormous sums on prescription drug coverage, yet the pricing behind it is layered with rebates, spread, and contract terms that are hard to compare. Fienberg's answer is not more complexity - it is clarity, delivered through data and independent analysis.

Latest Move

A "Center of Excellence" for pharmacy expertise


In 2026, under Fienberg's leadership, Truveris formally launched a Center of Excellence - a cross-functional team pulling together clinical strategy, PBM contract procurement and oversight, and data analytics under one roof. The goal is to give employers and benefit consultants access to deep expertise they would otherwise have to assemble piece by piece.

The Center of Excellence represents a deliberate investment in deeper clinical, contracting, and analytical expertise so our partners can navigate change and act with confidence. Garrett Fienberg
What it bundles

Expertise, made accessible

  • Clinical strategy for benefit design
  • PBM contract procurement and oversight
  • Pharmacy data analytics
  • Cost containment strategy for employers
The Arc

An operator across four industries


Fienberg did not come up through pharmacy. He came up through building and selling companies, and that outsider's route may be the point. His career has crossed software, energy services, professional sports media, and healthcare technology - and each chapter taught a version of the same lesson he now applies at Truveris: growth follows trust, and trust follows transparency.

Before Truveris, he was VP of Sales and Marketing Operations at Phreesia, a publicly traded healthcare SaaS company, where he drove roughly 50% annual sales growth and grew the sales development team from six people to more than 125 in five years. Earlier, he co-founded two venture-backed companies and served as President of Fulltime Fantasy Sports, which Sports Illustrated/Maven acquired in 2014.

  • 1990s-2000sVenture capital, hedge funds, investment banking and consulting - including JPMorgan Chase, Lucent New Ventures, and CSC Index
  • 2000sCo-founded Geovideo Networks (sold to WireOne Networks) and Intellicoat Technologies, an energy services startup
  • 2014President of Fulltime Fantasy Sports - acquired by Sports Illustrated / Maven
  • 2015-2021VP Sales & Marketing Operations at Phreesia; ~50% annual sales growth
  • 2021Joins Truveris as Head of Growth Operations
  • 2024Promoted to Chief Operating Officer
  • 2025Becomes Chief Executive Officer
  • 2026Launches the Truveris Center of Excellence
By The Numbers

The engine builder


6→125
SDR team scaled at Phreesia
~50%
Annual sales growth driven
5 yrs
To 20x the sales org
2
Startups founded & sold
Foundations

Education


Graduate

Kellogg School of Management

MBA, Northwestern University

Undergraduate

University of Michigan

BA in Economics and Political Science - summa cum laude

Who He Is

The operator's read


  • Growth-oriented, with a builder's instinct for scaling sales and go-to-market engines
  • Analytical - a Michigan economics background applied to opaque pricing
  • Entrepreneurial: has sat on both sides of the deal table, as founder and as operator
  • Cross-industry adaptability, from fantasy sports to healthcare technology
Questions

The quick brief


Who is Garrett Fienberg?
He is the Chief Executive Officer of Truveris, a pharmacy cost containment company focused on bringing transparency to PBM pricing for employers and benefit consultants.
What did he do before Truveris?
He co-founded and sold two venture-backed startups, was President of Fulltime Fantasy Sports (acquired by Sports Illustrated/Maven in 2014), and served as VP of Sales and Marketing Operations at Phreesia. His earlier career spanned venture capital, hedge funds, investment banking, and consulting.
When did he become CEO?
He joined Truveris in 2021, was promoted to Chief Operating Officer in March 2024, and stepped into the CEO role in 2025.
What is his education?
An MBA from the Kellogg School of Management and a BA in Economics and Political Science, summa cum laude, from the University of Michigan.
What does Truveris do?
Truveris built an independent, data-led technology platform that creates PBM pricing transparency and drives competition to reduce pharmacy costs for employers.
What is the Center of Excellence?
A cross-functional team of pharmacy and benefits experts - clinical, contracting, and analytics - launched in 2026 to help Truveris clients make stronger, more confident benefits decisions.
Connect

Find Garrett & Truveris


Share

Pass it on


Share this profile of the CEO reshaping pharmacy benefits transparency.